Loading viewer...
investor_presentation
Format: PDF investor_presentation
Chiasma's May 2018 business update highlights clinical achievements and regulatory progress, focusing on the CHIASMA OPTIMAL trial and future outlook.
investor_presentation
47 Pages
The First Bancshares, Inc.
Teva Pharmaceutical Industries Investor Presentation — October 2021
investor_presentationinvestor_presentation
39 Pages
Teva Pharmaceutical Industries